Corbion Future Growth
Future criteria checks 1/6
Corbion's revenue is forecast to decline at 0.2% per annum while its annual earnings are expected to grow at 8.7% per year. EPS is expected to grow by 18.6% per annum. Return on equity is forecast to be 11.3% in 3 years.
Key information
8.7%
Earnings growth rate
18.6%
EPS growth rate
Chemicals earnings growth | 21.0% |
Revenue growth rate | -0.2% |
Future return on equity | 11.3% |
Analyst coverage | Low |
Last updated | 30 Oct 2024 |
Recent future growth updates
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Corbion N.V. (AMS:CRBN)
Dec 18Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Nov 18An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued
Oct 31Corbion (AMS:CRBN) Takes On Some Risk With Its Use Of Debt
Sep 26The Price Is Right For Corbion N.V. (AMS:CRBN)
Jul 18Corbion N.V. (AMS:CRBN) Shares Could Be 25% Below Their Intrinsic Value Estimate
Jun 20Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely
May 08Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?
Apr 17Investor Optimism Abounds Corbion N.V. (AMS:CRBN) But Growth Is Lacking
Jan 20Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Dec 18Estimating The Fair Value Of Corbion N.V. (AMS:CRBN)
Nov 04Corbion (AMS:CRBN) Has A Somewhat Strained Balance Sheet
Sep 13Returns On Capital Signal Tricky Times Ahead For Corbion (AMS:CRBN)
Aug 04When Should You Buy Corbion N.V. (AMS:CRBN)?
Jul 14Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate
Jun 04Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden
Apr 21Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56
Mar 10Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?
Feb 22Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business
Jan 26Is Corbion (AMS:CRBN) Using Too Much Debt?
Dec 20Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
Nov 24Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Nov 09Corbion (AMS:CRBN) Might Be Having Difficulty Using Its Capital Effectively
Oct 08Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden
Sep 19A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
Aug 23Is It Time To Consider Buying Corbion N.V. (AMS:CRBN)?
Jul 21Investors Could Be Concerned With Corbion's (AMS:CRBN) Returns On Capital
Jul 06Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56
May 20Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
May 17Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56
Apr 28Corbion (AMS:CRBN) Has Announced A Dividend Of €0.56
Apr 07Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business
Mar 26Corbion (AMS:CRBN) Has Affirmed Its Dividend Of €0.56
Feb 27Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?
Feb 27At €37.02, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?
Feb 13A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
Jan 26Here's Why I Think Corbion (AMS:CRBN) Is An Interesting Stock
Dec 22Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business
Dec 10Is Corbion N.V. (AMS:CRBN) Worth €40.3 Based On Its Intrinsic Value?
Oct 25We Think Corbion (AMS:CRBN) Is Taking Some Risk With Its Debt
Sep 21Corbion (AMS:CRBN) Could Be Struggling To Allocate Capital
Sep 01I Ran A Stock Scan For Earnings Growth And Corbion (AMS:CRBN) Passed With Ease
Aug 17Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,396 | 103 | 55 | 169 | 5 |
12/31/2025 | 1,334 | 86 | 61 | 177 | 5 |
12/31/2024 | 1,298 | 90 | 57 | 135 | 5 |
6/30/2024 | 1,439 | 80 | 66 | 171 | N/A |
3/31/2024 | 1,442 | 77 | 41 | 168 | N/A |
12/31/2023 | 1,444 | 73 | 16 | 165 | N/A |
9/30/2023 | 1,380 | 57 | -61 | 121 | N/A |
6/30/2023 | 1,412 | 54 | -139 | 77 | N/A |
3/31/2023 | 1,435 | 72 | -168 | 58 | N/A |
12/31/2022 | 1,458 | 90 | -197 | 39 | N/A |
9/30/2022 | 1,350 | 76 | -190 | 32 | N/A |
6/30/2022 | 1,243 | 63 | -184 | 25 | N/A |
3/31/2022 | 1,157 | 70 | -155 | 24 | N/A |
12/31/2021 | 1,071 | 78 | -126 | 22 | N/A |
9/30/2021 | 1,040 | 97 | -65 | 59 | N/A |
6/30/2021 | 1,010 | 116 | -4 | 97 | N/A |
3/31/2021 | 998 | 95 | 8 | 103 | N/A |
12/31/2020 | 987 | 73 | 20 | 109 | N/A |
9/30/2020 | 992 | 49 | 20 | 108 | N/A |
6/30/2020 | 997 | 24 | 19 | 107 | N/A |
3/31/2020 | 987 | 25 | 29 | 111 | N/A |
12/31/2019 | 976 | 26 | 38 | 114 | N/A |
9/30/2019 | 953 | 37 | 39 | 109 | N/A |
6/30/2019 | 930 | 48 | 40 | 105 | N/A |
3/31/2019 | 914 | 51 | 40 | 102 | N/A |
12/31/2018 | 897 | 54 | 39 | 100 | N/A |
9/30/2018 | 883 | 61 | 56 | 109 | N/A |
6/30/2018 | 869 | 69 | 74 | 119 | N/A |
3/31/2018 | 880 | 77 | N/A | 118 | N/A |
12/31/2017 | 892 | 85 | N/A | 118 | N/A |
9/30/2017 | 905 | 87 | N/A | 109 | N/A |
6/30/2017 | 918 | 89 | N/A | 101 | N/A |
3/31/2017 | 914 | 95 | N/A | 112 | N/A |
12/31/2016 | 911 | 102 | N/A | 123 | N/A |
9/30/2016 | 917 | 103 | N/A | 124 | N/A |
6/30/2016 | 922 | 104 | N/A | 126 | N/A |
3/31/2016 | 920 | 91 | N/A | 118 | N/A |
12/31/2015 | 918 | 78 | N/A | 110 | N/A |
9/30/2015 | 885 | 45 | N/A | 93 | N/A |
6/30/2015 | 851 | 13 | N/A | 75 | N/A |
3/31/2015 | 811 | -4 | N/A | 71 | N/A |
12/31/2014 | 770 | -21 | N/A | 67 | N/A |
9/30/2014 | 757 | -15 | N/A | 51 | N/A |
6/30/2014 | 744 | -9 | N/A | 34 | N/A |
3/31/2014 | 744 | -3 | N/A | 22 | N/A |
12/31/2013 | 744 | 2 | N/A | 10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRBN's forecast earnings growth (8.7% per year) is above the savings rate (1.2%).
Earnings vs Market: CRBN's earnings (8.7% per year) are forecast to grow slower than the Dutch market (15.7% per year).
High Growth Earnings: CRBN's earnings are forecast to grow, but not significantly.
Revenue vs Market: CRBN's revenue is expected to decline over the next 3 years (-0.2% per year).
High Growth Revenue: CRBN's revenue is forecast to decline over the next 3 years (-0.2% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CRBN's Return on Equity is forecast to be low in 3 years time (11.3%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 01:09 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Corbion N.V. is covered by 24 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Robert Jan Vos | ABN AMRO Bank N.V. |
Setu Sharda | Barclays |
Fintan Ryan | Berenberg |